| Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 4.75 mm | 4.75 mm | 4.75 mm | 4.75 mm | 4.75 mm | |
| Cash burn (monthly) | (no burn) | 4.42 k | 710.00 k | 707.50 k | 756.17 k | |
| Cash used (since last report) | n/a | 12.33 k | 1.98 mm | 1.98 mm | 2.11 mm | |
| Cash remaining | n/a | 4.73 mm | 2.76 mm | 2.77 mm | 2.63 mm | |
| Runway (months of cash) | n/a | 1071.8 | 3.9 | 3.9 | 3.5 | |
| 13F holders | Current |
|---|---|
| Total holders | 5 |
| Opened positions | 5 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 5.16 bn |
| Total shares | 1.40 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Altium Capital Management | 1.18 mm | $5.01 bn |
| TEP Biotech | 204.91 k | $73.77 mm |
| Geode Capital Management | 14.88 k | $63.83 mm |
| Tower Research Capital | 2.58 k | $10.95 mm |
| UBS UBS | 899.00 | $3.82 mm |
| Proequities | 0.00 | $0.00 |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 22 Sep 23 | Leanne M. Kelly | Stock Option Common Stock | Grant | Acquire A | No | No | 1.52 | 83,333 | 126.67 k | 83,333 |
| 10 Aug 23 | David Leslie Szekeres | Stock Option Common Stock | Grant | Acquire A | No | No | 2.9 | 34,483 | 100.00 k | 34,483 |
| 10 Aug 23 | Roelof Rongen | Stock Option Common Stock | Grant | Acquire A | No | No | 2.9 | 34,483 | 100.00 k | 34,483 |
| 10 Aug 23 | Camilla V Simpson | Stock Option Common Stock | Grant | Acquire A | No | No | 2.9 | 34,483 | 100.00 k | 34,483 |
| 10 Aug 23 | David Charles Baker | Stock Option Common Stock | Grant | Acquire A | No | No | 2.9 | 34,483 | 100.00 k | 34,483 |
